Verdence Capital Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
14,342
-2,950
-17% -$159K 0.05% 300
2026
Q1
$904K Buy
17,292
+7,174
+71% +$431K 0.05% 308
2025
Q4
$595K Sell
10,118
-7,099
-41% -$431K 0.04% 378
2025
Q3
$1.11M Buy
17,217
+2,700
+19% +$145K 0.06% 288
2025
Q2
$747K Buy
14,517
+1,222
+9% +$61.4K 0.05% 306
2025
Q1
$779K Buy
13,295
+1,328
+11% +$90K 0.06% 281
2024
Q4
$862K Buy
11,967
+173
+1% +$12.7K 0.07% 270
2024
Q3
$943K Buy
11,794
+717
+6% +$53.9K 0.08% 261
2024
Q2
$794K Sell
11,077
-159
-1% -$11.7K 0.07% 272
2024
Q1
$791K Buy
11,236
+4,523
+67% +$324K 0.07% 274
2023
Q4
$518K Sell
6,713
-2,885
-30% -$190K 0.05% 331
2023
Q3
$653K Buy
9,598
+556
+6% +$43.9K 0.07% 275
2023
Q2
$738K Buy
9,042
+1,426
+19% +$115K 0.09% 245
2023
Q1
$565K Buy
+7,616
New +$587K 0.07% 291
2022
Q4
Sell
-7,444
Closed -$529K 551
2022
Q3
$529K Buy
7,444
+168
+2% +$14.5K 0.07% 262
2022
Q2
$631K Buy
7,276
+2,600
+56% +$244K 0.08% 250
2022
Q1
$506K Buy
4,676
+240
+5% +$24.8K 0.06% 296
2021
Q4
$574K Sell
4,436
-388
-8% -$47.6K 0.07% 266
2021
Q3
$584K Buy
4,824
+1,244
+35% +$151K 0.08% 250
2021
Q2
$403K Buy
+3,580
New +$377K 0.06% 291

Other funds holding TECH

Verdence Capital Advisors's TECH Position: Q2 2026 in Review

Verdence Capital Advisors reduced its Bio-Techne (TECH) stake by 17% in Q2 2026, selling an estimated $159K and leaving 14,342 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #300.

Verdence Capital Advisors first reported a position in TECH in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.11M in Q3 2025. 196 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Verdence Capital Advisors held 14,342 shares of Bio-Techne worth $1.01M as of Q2 2026.
  • Verdence Capital Advisors sold 2,950 Bio-Techne shares in Q2 2026, an estimated $159K.
  • Bio-Techne made up 0.05% of Verdence Capital Advisors's portfolio in Q2 2026, its #300 holding.
  • Verdence Capital Advisors first reported a position in Bio-Techne in Q2 2021 and has held it in 20 quarters since.
  • Verdence Capital Advisors's Bio-Techne position peaked at $1.11M in Q3 2025.
  • 196 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.